Elias D, Naudeix E, Ducreux M, Lusinchi A, Goharin A, Ouelette J F, Lasser P
Department of Digestive Oncological Surgery, Medical Oncology, and Radiotherapy, Institut Gustave Roussy, Comprehensive Cancer Center, Villejuif, France.
Hepatogastroenterology. 2001 Jan-Feb;48(37):123-7.
BACKGROUND/AIMS: To analyze the results of surgery for macroscopically or radiologically obvious (i.e., easily detectable by computed tomography scan or by palpation) synchronous or metachronous lateroaortic lymph node metastases from colorectal primaries.
Thirty-one highly selected patients who underwent a lateroaortic lymphadenectomy for obvious lateroaortic lymph node metastases from January 1989 to January 1999 were analyzed retrospectively. An associated metastatic lesion was present in 68% of the cases before or concomitantly with the lateroaortic lymph node metastases. Ten lateroaortic lymph node metastases were synchronous with the primary, and 21 were metachronous. Decision for lymphadenectomy was taken after a multidisciplinary meeting and a period of observation. Median follow-up after lymphadenectomy was 24.2 months (range: 6-120). All the patients received at least two systemic lines of chemotherapy before or after the lateroaortic lymphadenectomy.
There was no postoperative mortality. Resection was macroscopically complete (R0-1 of UICC) in 26 cases (84%). Twenty-six (83.8%) patients developed recurrent lesions or had progressive residual disease. The most frequent first site of recurrence was intrathoracic (54.8%) for the entire series, except for the subgroup of isolated lateroaortic lymph node metastases in which recurrent lesions were mainly lateroaortic. Three-year global and disease-free survival rates were, respectively, 39% and 9.6%. No significant difference was noted in survival between lateroaortic lymph node metastases that were synchronous or metachronous with the primary. However, the most important prognostic factor was the presence of associated metastases. Indeed 3-year survival attained 30% when lateroaortic lymph node metastases were isolated but 0% when lateroaortic lymph node metastases were associated with another metastatic site (P = 0.006).
Obvious lateroaortic lymph node metastasis is rarely isolated. However, when it is isolated, in selected cases (objective response to systemic chemotherapy, good general status), resection can be beneficial whatever its synchronous or metachronous appearance.
背景/目的:分析因结直肠癌原发灶出现肉眼或影像学上明显(即通过计算机断层扫描或触诊易于检测到)的同期或异时性主动脉旁淋巴结转移而进行手术的结果。
回顾性分析了1989年1月至1999年1月期间31例因明显的主动脉旁淋巴结转移而接受主动脉旁淋巴结清扫术的高度选择患者。68%的病例在主动脉旁淋巴结转移之前或同时存在相关转移病灶。10例主动脉旁淋巴结转移与原发灶同期出现,21例为异时性。在多学科会诊和一段时间观察后决定进行淋巴结清扫术。淋巴结清扫术后的中位随访时间为24.2个月(范围:6 - 120个月)。所有患者在主动脉旁淋巴结清扫术前或术后至少接受了两线全身化疗。
无术后死亡病例。26例(84%)患者的手术切除在肉眼下达到完全切除(UICC的R0 - 1)。26例(83.8%)患者出现复发病灶或有疾病进展的残留病灶。整个系列中最常见的复发部位是胸腔内(54.8%),但孤立性主动脉旁淋巴结转移亚组除外,该亚组的复发病灶主要在主动脉旁。三年总生存率和无病生存率分别为39%和9.6%。主动脉旁淋巴结转移与原发灶同期或异时出现的患者在生存率上无显著差异。然而,最重要的预后因素是是否存在相关转移。实际上,当孤立性主动脉旁淋巴结转移时,三年生存率为30%,但当主动脉旁淋巴结转移与另一个转移部位相关时,三年生存率为0%(P = 0.006)。
明显的主动脉旁淋巴结转移很少是孤立性的。然而,当它是孤立性时,在特定病例中(对全身化疗有客观反应,一般状况良好),无论其同期或异时出现,手术切除可能有益。